Nu Skin sees FY25 EPS $3.05-$3.25

Sees $1.15 to $1.35 excluding Mavely gain and other charges, consensus $1.04. Sees revenue $1.48B-$1.55B, (15)% to (11)% or (11)% to (7)% excluding Mavely 2024 revenue, consensus $1.76B. “We are encouraged by the positive results of our ongoing efforts to improve overall profitability, which has generated significant cash and further strengthened our balance sheet,” said James D. Thomas, chief financial officer. “Notably, we’ve achieved our goal of reaching a positive net cash position ahead of schedule, marking the first time in more than 4 years that we’ve been in such a position. Based on our first-half results and greater clarity into performance and consumer sentiment through the end of the year, we are narrowing our revenue and increasing our earnings guidance. For 2025, we project revenue of $1.48 billion to $1.55 billion and earnings per share of $3.05 to $3.25 with adjusted EPS of $1.15 to $1.35. For the third quarter, we project revenue between $360 million and $390 million, with earnings per share in the range of $0.25 to $0.35.”